First Heartland Consultants’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$707K Sell
1,400
-4
-0.3% -$2.07K 0.05% 272
2026
Q2
$654K Buy
1,404
+178
+15% +$74.8K 0.04% 281
2026
Q1
$463K Buy
1,226
+2
+0.2% +$857 0.04% 299
2025
Q4
$524K Buy
1,224
+264
+28% +$115K 0.04% 286
2025
Q3
$430K Buy
960
+115
+14% +$52.1K 0.03% 316
2025
Q2
$411K Buy
845
+172
+26% +$98K 0.04% 314
2025
Q1
$414K Buy
673
+42
+7% +$23.9K 0.04% 273
2024
Q4
$334 Buy
631
+123
+24% +$69.3K ﹤0.01% 448
2024
Q3
$305K Buy
508
+34
+7% +$19.3K 0.03% 325
2024
Q2
$257K Buy
474
+76
+19% +$43.5K 0.02% 370
2024
Q1
$255K Buy
+398
New +$242K 0.03% 360

Other funds holding CHE

First Heartland Consultants's CHE Position: Q3 2026 in Review

First Heartland Consultants reduced its Chemed (CHE) stake by 0.28% in Q3 2026, selling an estimated $2.07K and leaving 1,400 shares worth $707K. The position accounts for 0.05% of the portfolio, ranked #272.

First Heartland Consultants first reported a position in CHE in Q1 2024 and has held it in 11 quarters since. 16 funds tracked by Wall St. Rank hold CHE as of Q3 2026.

  • First Heartland Consultants held 1,400 shares of Chemed worth $707K as of Q3 2026.
  • First Heartland Consultants sold 4 Chemed shares in Q3 2026, an estimated $2.07K.
  • Chemed made up 0.05% of First Heartland Consultants's portfolio in Q3 2026, its #272 holding.
  • First Heartland Consultants first reported a position in Chemed in Q1 2024 and has held it in 11 quarters since.
  • 16 funds tracked by Wall St. Rank held Chemed as of Q3 2026.

Based on First Heartland Consultants's 13F filing for Q3 2026, filed 8 Oct 2026.